Emunamedica LLC is a non-invasive wound diagnostic company focused on offering products that assist clinicians in providing better outcomes for patients in a cost-effective manner. Our initial product, the Emuna1000(TM) is designed to assess wound healing in diabetic foot ulcer, venous ulcer and pressure ulcer wounds more accurately, faster and in a less expensive manner relative to both standard of care and other wound healing assessment devices.

Why is this important to patients?

Because the longer it takes for a wound to heal, the worse the prognosis. We believe that with more accurate information clinicians can make better decisions regarding any changes in patient therapy, potentially improving patient outcomes and lowering the incidence of lower extremity amputations.

Why is this important to clinicians?

Because today's gold standard of wound size measurement is antiquated and is less than 60% accurate for wound healing. Better information can mean higher productivity for clinicians.

Why is this important to insurance companies, Medicare and others?

Because these groups spend $15 billion per year on wound therapies and have yet to see a significant reduction in amputation rates, healing rates or mortality rates relating to these lower extremity wounds.

Emunamedica's mission is to provide tools to wound care clinicians to drive better patient outcomes.